Dr. Mehmet Oz emphasizes the importance of protecting Medicare from fraud, while Lantern Pharma Inc. launches an AI tool to predict cancer drug efficacy. DeLorean AI's CEO, Dr. Severence MacLaughlin, shares insights on their journey to predictive healthcare success. Additionally, Nutriband Inc. tackles drug-delivery challenges, and FDA-cleared innovations like the HeartBeam system and Soligenix Inc.'s HyBryte(TM) platform aim to revolutionize cardiac care and rare disease treatment, respectively. Moreover, a recent genetic discovery holds promise for enhancing cancer immunotherapy outcomes, showcasing ongoing advancements in the healthcare industry.